Haemotherapy for acute haemorrhage.
In this review blood component therapy for acute haemorrhage is summarised. As the haemotherapy is frequently the cornerstone of a successful outcome of haemorrhagic shock, attention to details in relation to the indications, safety and efficiency is essential. Massive blood transfusion brings with it many potential complications which may jeopardise a successful outcome for the patient after skillful medical and surgical care has controlled the basic problem.
D000137:Acid-Base Imbalance / Q000209:etiology; D000208:Acute Disease; D001793:Blood Preservation; D001803:Blood Transfusion; D017707:Erythrocyte Transfusion; D004912:Erythrocytes / Q000378:metabolism; D006470:Hemorrhage / Q000628:therapy*; D006489:Hemostatic Techniques; D006801:Humans; D007244:Infectious Mononucleosis / Q000209:etiology; D007565:Jaundice / Q000209:etiology; D010101:Oxygen Consumption; D011654:Pulmonary Edema / Q000209:etiology; D065227:Transfusion Reaction; D014883:Water-Electrolyte Imbalance / Q000209:etiology